Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:GSKNYSE:MRK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGSKGSK$35.92+1.5%$37.44$31.72▼$45.93$72.98B0.564.64 million shs4.81 million shsMRKMerck & Co., Inc.$77.93+1.9%$87.64$75.93▼$134.63$192.81B0.411.69 million shs21.31 million shsElon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGSKGSK+1.51%+6.75%-10.98%+7.35%-9.31%MRKMerck & Co., Inc.+1.98%+0.66%-17.69%-20.48%-37.83%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGSKGSK2.8113 of 5 stars2.35.02.50.03.20.01.3MRKMerck & Co., Inc.4.9993 of 5 stars4.33.05.03.93.23.33.8Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGSKGSK 2.55Moderate Buy$40.5813.00% UpsideMRKMerck & Co., Inc. 2.64Moderate Buy$115.5048.20% UpsideCurrent Analyst Ratings BreakdownLatest MRK and GSK Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/17/2025MRKMerck & Co., Inc.GuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$115.00 ➝ $115.004/15/2025GSKGSKBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$35.252/18/2025MRKMerck & Co., Inc.Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$128.00 ➝ $105.002/12/2025GSKGSKMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight2/12/2025MRKMerck & Co., Inc.GuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$122.00 ➝ $115.002/10/2025MRKMerck & Co., Inc.TD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$121.00 ➝ $100.002/10/2025MRKMerck & Co., Inc.TD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$121.00 ➝ $100.002/5/2025MRKMerck & Co., Inc.Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$118.00 ➝ $112.002/5/2025MRKMerck & Co., Inc.BMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$105.00 ➝ $96.002/5/2025MRKMerck & Co., Inc.CitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$125.00 ➝ $115.002/5/2025MRKMerck & Co., Inc.Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$113.00 ➝ $106.00(Data available from 4/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGSKGSK$31.38B2.36$5.68 per share6.32$8.07 per share4.45MRKMerck & Co., Inc.$64.17B3.06$2.70 per share28.82$14.85 per share5.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGSKGSK$3.29B$1.5922.597.721.128.13%48.59%11.11%4/30/2025 (Estimated)MRKMerck & Co., Inc.$17.12B$6.7311.587.870.7726.67%45.35%17.36%4/24/2025 (Estimated)Latest MRK and GSK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2025Q1 2025GSKGSK$1.06N/AN/AN/A$7.52 billionN/A4/24/2025Q1 2025MRKMerck & Co., Inc.$2.16N/AN/AN/A$15.59 billionN/A2/5/2025Q4 2024GSKGSK$0.44$0.59+$0.15$0.26$7.75 billionN/A2/4/2025Q4 2024MRKMerck & Co., Inc.$1.85$1.72-$0.13$1.48$15.51 billion$15.62 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGSKGSK$1.604.45%-17.33%100.63%N/AMRKMerck & Co., Inc.$3.244.16%+5.73%48.14%14 YearsLatest MRK and GSK DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/5/2025GSKGSKquarterly$0.39324.2%2/21/20252/21/20254/10/20251/28/2025MRKMerck & Co., Inc.quarterly$0.813.32%3/17/20253/17/20254/7/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGSKGSK1.120.780.52MRKMerck & Co., Inc.0.791.361.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGSKGSK15.74%MRKMerck & Co., Inc.76.07%Insider OwnershipCompanyInsider OwnershipGSKGSK10.00%MRKMerck & Co., Inc.0.09%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGSKGSK90,1002.06 billion1.87 billionOptionableMRKMerck & Co., Inc.69,0002.52 billion2.53 billionOptionableMRK and GSK HeadlinesRecent News About These CompaniesMERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. ...April 17 at 9:30 PM | gurufocus.comMERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmApril 17 at 9:00 PM | globenewswire.comMerck & Co., Inc. (NYSE:MRK) Stock Price Down 0.7% - Time to Sell?April 17 at 3:57 PM | marketbeat.comIs Merck & Co., Inc. (MRK) The Dirt Cheap Stock To Invest In Now?April 17 at 1:30 PM | insidermonkey.comMerck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseApril 17 at 11:07 AM | zacks.comHere is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending StockApril 17 at 10:05 AM | zacks.comMerck & Co., Inc. (MRK): Among the Innovative Healthcare Stocks to Watch in 2025April 17 at 10:02 AM | insidermonkey.comGreenwood Gearhart Inc. Boosts Holdings in Merck & Co., Inc. (NYSE:MRK)April 17 at 7:29 AM | marketbeat.comAdvent Capital Management DE Has $2.49 Million Holdings in Merck & Co., Inc. (NYSE:MRK)April 17 at 7:29 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Stock Holdings Cut by Zacks Investment ManagementApril 17 at 7:21 AM | marketbeat.comNewEdge Advisors LLC Has $40.86 Million Holdings in Merck & Co., Inc. (NYSE:MRK)April 17 at 6:52 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Main Street Financial Solutions LLCApril 17 at 6:19 AM | marketbeat.comEvergreen Capital Management LLC Acquires 41,947 Shares of Merck & Co., Inc. (NYSE:MRK)April 17 at 6:01 AM | marketbeat.comMicrofiltration Membranes Market Research - Global Forecast to 2029 with Merck, Sartorius, and Pall LeadingApril 17 at 5:57 AM | globenewswire.comMerck & Co., Inc. (NYSE:MRK) Stock Holdings Decreased by United Capital Financial Advisors LLCApril 17 at 5:52 AM | marketbeat.comMerck & Co., Inc. (MRK) to Release Earnings on ThursdayApril 17 at 3:29 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Trading Down 0.7% - Here's WhyApril 16 at 3:03 PM | marketbeat.comIs Merck & Co Inc. (NYSE:MRK) the Most Undervalued Quality Stock to Buy Now?April 16 at 1:19 PM | msn.comIs Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth?April 16 at 1:19 PM | msn.comGabelli Funds LLC Purchases 19,084 Shares of Merck & Co., Inc. (NYSE:MRK)April 16 at 7:19 AM | marketbeat.comAnchor Investment Management LLC Sells 4,431 Shares of Merck & Co., Inc. (NYSE:MRK)April 16 at 6:55 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMRK and GSK Company DescriptionsGSK NYSE:GSK$35.92 +0.55 (+1.54%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$35.74 -0.18 (-0.50%) As of 04/17/2025 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.Merck & Co., Inc. NYSE:MRK$77.93 +1.47 (+1.93%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$78.01 +0.08 (+0.10%) As of 04/17/2025 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally Rocket Lab's Growth Potential Gains Altitude on Defense News Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk Tariff-Resistant Abbott Laboratories on Track for New Highs Goldman Sachs Just Revealed What’s Next for Markets United Airlines Is in Reversal—If the Economy Doesn’t Stall Buy the Boeing Dip Even on Tariff and Bans? Spotify Stock Climbs as Its Growth Strategy Diversifies Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
